What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
The DOI matches its Crossref record.
Abstract
The authors provide an overview of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study (www.star-d.org), a large-scale practical clinical trial to determine which of several treatments are the most effective "next-steps" for patients with major depressive disorder whose symptoms do not remit or who cannot tolerate an initial treatment and, if needed, ensuing treatments. Entry criteria were broadly defined and inclusive, and patients were enrolled from psychiatric and primary care clinics. All participants began on citalopram and were managed by clinic physicians, who followed an algorithm-guided acute-phase treatment through five visits over 12 weeks. At the end of each sequence, patients whose depression had not fully remitted were eligible for subsequent randomized trials in a sequence of up to three clinical trials. In general, remission rates in the study clinics were lower than expected, suggesting the need for several steps to achieve remission for most patients. There was no clear medication "winner" for patients whose depression did not remit after one or more aggressive medication trials. Both switching and augmenting appeared to be reasonable options when an initial antidepressant treatment failed, although these two strategies could not be directly compared. Further, the likelihood of remission after two vigorous medication trials substantially decreased, and remission would likely require more complicated medication regimens for which the existing evidence base is quite thin. STAR*D demonstrated that inclusion of more real-world patients in clinical trials is both feasible and informative. Policy implications of the findings, as well as the study's limitations, are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“low efficacy (only 27% of depressed patients achieved remission after 12 weeks of citalopram treatment as measured by HAM-D)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [259]
In the citing paper
“the current standard of care treatments suffer from slow onset (e.g., 7 week average response time with citalopram)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [259]
In the citing paper
“Studies examining antidepressant efficacy reveal 30% of depressed patients fail to respond to common antidepressant treatment (1)”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [1]
In the citing paper
“Currently available antidepressant medications, alone and in combination, are associated with high rates of partial- or non-response, delayed response onset of weeks to months, and limited duration of efficacy5.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [5]
In the citing paper
“while more than a third fail to achieve remission even after several rounds of treatment ( Al-Harbi, 2012 , Gaynes et al., 2009 , Strawbridge et al., 2022 )”
From Self-blame-selective hyper-connectivity between anterior temporal and subgenual cortices predicts prognosis in major depressive disorder (2023) · cites this paper as Gaynes et al., 2009
Citations
Cites
Still being checked.
Cited by
Items 701–764 of 764
Massé-Leblanc, C. (2023) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/31618
Njau, S. N. (2024) · eScholarship (California Digital Library)
Esketamina e Depressão Resistente ao Tratamento: Revisão Sistemática
Rato, M. A. B. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Neuropsychological mechanisms of ketamine antidepressant effect
Costi, S. (2025) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-wvydgvb7o
O’Shields, J., Soni, H., & Mowbray, O. P. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106243
CDA-AMC (2026) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2026.1327
Investigação da toxicidade e atividade antidepressiva-símile do o-Eugenol em camundongos fêmeas
de Abrantes, A. F. F. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Reconsideration of the lifetime limit of 50 rebated TMS sessions
PRIDMORE, S. A., Turnier‐Shea, Y., Rybak, M., & Peterson, G. M. (2026) · Australasian Psychiatry · doi:10.1177/10398562261431257
verma, S. (2025) · TSpace (University of Toronto)
Rosenblat, J. D. (2020) · TSpace (University of Toronto)
Elfaki, L. A. (2023) · TSpace (University of Toronto)
Drouvé, N. (2026) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Peña, L. J. V. (2025) · Academica-e (Universidad Pública de Navarra)
il cibo cura la mente: neuronutrizione e psichiatria nutrizionale
CELESTINO, R. (2026) · Electronic Theses and Dissertations Repository (University of Pisa)
Potentialisation de la réponse antidépressive grâce au blocage combiné du récepteur 5-HT3 et du SERT
Betry, C. (2012) · theses.fr (ABES) · doi:10.70675/f91be776zef1bz46a1z9ad8z3b478b0ee103
Novozhenova, A. N., Dolotov, O. V., & Grivennikov, I. A. (2025) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416825700417
Gant, J., Perryman, D. C., & Coveart, S. (2026) · Mental Health Clinician · doi:10.9740/mhc.2026.04.054
Neurobiological mechanisms underlying treatment-resistant depression: An integrative review
Hoffmann, M., & Richter, A. (2026) · International Journal of Psychiatry Research · doi:10.33545/26648962.2026.v8.i1a.125
Cohort Profile: Investigating Antidepressant Response within Generation Scotland
Calnan, M., Edmondson-Stait, A. J., Milbourn, H., Elsden, E., Henders, A. K., Ball, E. L., Iveson, M. H., Panel, A. L. E. A., Generation Scotland Team, Wray, N. R., et al. (2026) · Wellcome Open Research · doi:10.12688/wellcomeopenres.26056.1
Viniegra, J. P. B. (2026) · Cureus · doi:10.7759/cureus.107343
Emerging Therapeutic Interventions for Treatment‑Resistant Depression
Tamez, M. C. C., Scaini, G., & Quevedo, J. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-6872-7_26
Mental Health Promotion in the Personal Trainer–Client Relationship: A Cross‐Sectional Analysis
Dissanayake, I., Lederman, O., Ali, K., Home, R. L., & Fassnacht, D. B. (2026) · Health Promotion Journal of Australia · doi:10.1002/hpja.70194
Wigg, C. (2026) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-do19v6jpe
Behle, N. (2026) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.36932
Zeeuws, D., Bernagie, K., Bruecker, G. D., Claeys, I., Evenepoel, C., Donck, F. V., Smeets, D., & Peeters, E. (2026) · Interactive Journal of Medical Research · doi:10.2196/86448
Suen, P. J. C., Cavendish, B. A., Batista, M. T., Passos, I. C., Vidal, K. S. M., & Brunoni, A. R. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02266-2
Chapter 2. Transcranial Magnetic Stimulation Therapy for Major Depression
Lanocha, K. I., Bermudes, R. A., & Janicak, P. G. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550671.lg02
Monteiro, D. C., de, E. K., Ramos, C. S., Germoglio, C. D. M., da Silva, E. C. A., de Paula, R. R., & Amorim, J. K. D. A. (2026) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1177/25785478261456433
Lee, H., Castillo, W. C., Rose, R. A., Reeves, G. M., Qato, D. M., & dosReis, S. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122057
Pharmacotherapy context shapes CYP2C19, CYP2D6 and CYP2B6 effects on antidepressant switchingPreprint
Wray, N. R., Walker, A., Klont, F., Pearson, E. R., Cipriani, A., Taquet, M., & Hak, E. (2026) · Research Square · doi:10.21203/rs.3.rs-9928103/v1
Zhang, S., Zhang, Z., Li, X., Zhou, J., Li, R., Liu, R., Wang, Y., Chen, X., Feng, Y., Cui, J., et al. (2026) · Depression and Anxiety · doi:10.1155/da/4701907
Paribello, P., Isayeva, U., Lazzardi, S., Pinna, M. A., Contu, M., Meloni, A., Pisanu, C., Squassina, A., Baune, B. T., & Manchia, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1819237
van Zwieten, N., Aalbers, G., Lamers, F., Riese, H., Hillegers, M. H. J., & Penninx, B. W. J. H. (2026) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.70085
Dalati, Y. (2026) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-51105
Johnston, J. N., Jones, G. H., Peng, S., Yuan, P., Yavi, M., Kadriu, B., Henter, I. D., Quintanilla, B., Elkahloun, A. G., Moaddel, R., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03768-0
Bon, J., Saje, M., Tudor, L., Perković, M. N., Oblak, A., Perellón‐Alfonso, R., Kuclar, M., & Paska, A. V. (2026) · Research Square · doi:10.21203/rs.3.rs-10472628/v1
Fleury, S., Chang, L. J., & Nautiyal, K. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.24.740586
Choi, W.-S., Lee, M., Seo, M. K., Jang, O., & Lee, J. G. (2026) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.26.1457
Lee, J. G., & Park, Y.-M. (2026) · Springer eBooks · doi:10.1007/978-981-92-1331-3_11
Moreira, R., Frade, P., Campeão, N., Gomes, S., Lopes, A. D. M., Lapa, G., Vian, J., Fonseca, A., Polido, F., Barata, B. C., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1749006
Treatment Selection for Major Depressive Disorder in Veterans Health Administration Outpatients
Aslan, M., Tylee, D. S., Chen, P., Yi, D., Li, Y., Mutalik, P., Yan, L., Huang, X., Polimanti, R. A., Wang, Z., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.28853
Regonia, P. R. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.34413/dr.01848
Zavaliangos‐Petropulu, A., Pfeiffer, P., Crawford, M., Norris, V., Espinoza, R. T., Wu, P., Kruse, J. L., Abbott, C., McClintock, S. M., Sheline, Y. I., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10683316/v1
Amiri, D., Shah, S., Briziarelli, L., Amiri, S., & Karlsson, B. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16090468
Wang, R., Wu, F., Zhu, X., Feng, L., Zhang, L., Liu, S., Jin, C., & Wang, G. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04440-5
A complex intervention perspective on psychedelic-assisted psychotherapy: the role of music
Bacchi, P. S., Barbosa, S. L., Tomazela, J. V., Lemes, P. S., Koning, E., & Brietzke, E. M. (2026) · npj Mental Health Research · doi:10.1038/s44184-026-00243-0
Roberts, B. (2026) · UWA Profiles and Research Repository (UWA) · doi:10.26182/2sk7-0w50
Targeting the serotonin 1B receptor for the treatment of depression and anxiety
Fleury, S., & Nautiyal, K. M. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2738183
ปัจจัยที่สัมพันธ์กับระดับอาการที่ดีขึ้นของโรคซึมเศร้าภายหลังการรักษา 5 ถึง 11 สัปดาห์ด้วยยาต้านเศร้า
Lortrakul, J., Wannarit, K., Pukrittayakamee, P., Saisavoey, N., & Chantakarn, S. (2020) · Biomedical Sciences and Clinical Medicine
Neuroplasticity-Based Treatment Prioritization in Major Depressive Disorder: A Two-Cohort StudyPreprint
Solal, T. C., Amiaz, R., Maman, M., Kassner, Z., Keller, G., Ami, D. B., Jaremko, M., Aloni, E., Goldman, O., Fava, M., et al. (2026) · medRxiv · doi:10.64898/2026.10.06.26364759
Self-citationPfeiffer, P., Zavaliangos‐Petropulu, A., Taraku, B., Schneider, J., Norris, V., Kozikowski, S. D., Woods, R., Boucher, M., Jog, M., & Narr, K. L. (2026) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2026.09.014
Analytic Methods for SMART Designs Incorporating Patient Treatment Preferences
Ferlito, S. (2026) · Deep Blue (University of Michigan) · doi:10.7302/dspace/30608
Chapter 2. Inflammation in the Brain and the Body
(2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550930.lg02
Fleury, S., Shang, Y., & Nautiyal, K. M. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07184-8
Harris, J. R., van Haarst, A. D., Baccei, J., FRANEY, B. B., Everett, J., George, K., Paglialunga, S., Webster, K., Hillstrand, M., Banfield, C., et al. (2026) · Clinical and Translational Science · doi:10.1111/cts.70743
Transcriptional profiles of CD4+ and CD8+ T cells in major depressive disorderPreprint
Cathomas, F., Chan, K., Shimo, Y., Ramakrishnan, A., Parise, L. F., Lin, H.-Y., Alvarez, J., Dirupo, G., Karpman, E., Fisher-Foye, R. L., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11516320/v1
Falkowska, M., Niels R. Ntamati, Nevian, N. E., Nevian, T., & Acuña, M. A. (2023) · doi:10.3389/fnbeh.2023.1139205.s001
Chen, Y., Shen, M., Liu, X., Xu, J., & Wang, C. (2022) · doi:10.3389/fnbeh.2022.789524.s003
Oliveira-Maia, A. J., Rive, B., Morrens, J., Godinov, Y., Cabrieto, J., Perualila, N., & Mulhern-Haughey, S. (2023) · doi:10.3389/fpsyt.2023.1250987.s002
Regonia, P. R., Takamura, M., Nakano, T., Ichikawa, N., Fermin, A., Okada, G., Okamoto, Y., Yamawaki, S., Ikeda, K., & Yoshimoto, J. (2021) · doi:10.3389/fpsyt.2021.780997.s001
Oliveira-Maia, A. J., Morrens, J., Rive, B., Godinov, Y., Cabrieto, J., Perualila, N., Barbreau, S., & Mulhern-Haughey, S. (2023) · doi:10.3389/fpsyt.2023.1250980.s002
EXPERIMENTAL MEASUREMENT OF BEHAVIORAL APPROACH MOTIVATION IN MAJOR DEPRESSIVE DISORDER
Szczepanik, J. E. (2015) · University Libraries (University of Maryland) · doi:10.13016/m2j044
Metadata
- Authors
- Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- The University of Texas Southwestern Medical Center (US)
- University of Pittsburgh (US)
- National University of Singapore (SG)
- Venue
- Psychiatric Services
- Published
- 2009-11
- Volume
- 60
- Issue
- 11
- Pages
- 1439-1445
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2095852687
- Cited by
- 661
- References
- 0
- Citations by year
- 2026: 37 · 2025: 47 · 2024: 57 · 2023: 73 · 2022: 61 · 2021: 58 · 2020: 55 · 2019: 48 · 2018: 41 · 2017: 42 · 2016: 28 · 2015: 33 · 2014: 20 · 2013: 20 · 2012: 16
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatric Services (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- University of Texas Southwestern Medical Center
- National Institutes of Health (n01mh90003-26-0-0)
- National Institute of Mental Health (N01‐MH‐90003)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- STAR*D, major depressive disorder, antidepressant treatment, treatment-resistant depression, remission, citalopram, antidepressant switching, antidepressant augmentation, primary care, psychiatric clinic
- MeSH terms
- Venlafaxine Hydrochloride, Adolescent, Adult, Aged, Cyclohexanols, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Primidone, Remission Induction, Time Factors, Citalopram, Cognitive Behavioral Therapy, Bupropion, Treatment Outcome, Treatment Failure, Selective Serotonin Reuptake Inhibitors, Dopamine Uptake Inhibitors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.